Emergency Contraception: Harder to Access Than It Should Be – BPAS
British Pregnancy Advisory Service (BPAS) shared a post on LinkedIn:
“Emergency contraception is a safe, effective and time-sensitive medicine. So why is it still harder to access than it should be?
At BPAS, we are calling for the reclassification of emergency contraception to General Sales List (GSL) status. This simple regulatory change would allow it to be sold in a wider range of retail outlets, including supermarkets, improving access when every hour matters.
This isn’t a new or radical proposal. Countries including Sweden, Norway and the United States already provide off-the-shelf access, and the change is supported by expert groups.
We’re proud to be working alongside the CoSRH – College of Sexual and Reproductive Healthcare to make the case for reclassification and remove unnecessary barriers to this safe, time-sensitive medicine.
Improving access to emergency contraception means giving women more opportunities to prevent an unintended pregnancy – and ensuring access reflects the urgency of the medicine.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 2, 2026, 14:37Engaging with the Obstetrics and Gynaecology Community at SOGC – FIGO
-
Jul 2, 2026, 14:34Julie Morgan: How Do We Care for Patients We Can’t See?
-
Jul 2, 2026, 14:28Khalil Faaed: Are Transfer Cannulas an Overlooked Variable in IVF Success?
-
Jul 2, 2026, 14:20Antonio La Marca: Uterine Artery Embolization for Adenomyosis and Fibromatosis!
-
Jul 2, 2026, 14:15The Post-Reproductive Ovary Shifts From a Reproductive to an Immune-Like Organ – ReproScientifics – SpermTracer
-
Jul 2, 2026, 12:09Micah Hill: I am So Excited to See Many of You at ESHRE Starting This Weekend
-
Jul 2, 2026, 12:01Our Milestone 50th Issue of RBMO Insights Is Out Now – RBMO
-
Jul 2, 2026, 11:44Tammy Lee: 2.1PN Zygotes Can Be Viable and Deserve Separate Classification
-
Jul 2, 2026, 11:34Biochemical Pregnancies Affect Up to 31% of IVF Cycles – Fertility Plus